tiprankstipranks
Immune Therapeutics (IMUN)
OTHER OTC:IMUN
US Market

Immune Therapeutics (IMUN) Technical Analysis

9 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
3Neutral
16Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Immune Therapeutics’s (IMUN) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting Immune Therapeutics is a Sell.
Immune Therapeutics’s (IMUN) 20-Day exponential moving average is 0.11, while Immune Therapeutics’s (IMUN) share price is <$0.1, making it a Sell.
Immune Therapeutics’s (IMUN) 50-Day exponential moving average is 0.19, while Immune Therapeutics’s (IMUN) share price is <$0.1, making it a Sell.

Immune Therapeutics (IMUN) Pivot Points

Apr 27, 2024, 10:49 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.05
0.06
0.07
0.09
0.10
0.12
0.13
Fibonacci
0.06
0.07
0.08
0.09
0.10
0.10
0.12
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immune Therapeutics (IMUN) Moving Averages

Apr 27, 2024, 10:49 PM
Period
Simple
Exponential
MA5
0.09Sell
0.09Sell
MA10
0.09Sell
0.09Sell
MA20
0.10Sell
0.11Sell
MA50
0.18Sell
0.19Sell
MA100
0.35Sell
0.31Sell
MA200
0.48Sell
0.48Sell
Immune Therapeutics’s (IMUN) 10-Day exponential moving average is 0.09, while Immune Therapeutics’s (IMUN) share price is <$0.1, making it a Sell.
Immune Therapeutics’s (IMUN) 100-Day exponential moving average is 0.31, while Immune Therapeutics’s (IMUN) share price is <$0.1, making it a Sell.
Immune Therapeutics’s (IMUN) stock price is <$0.1 and Immune Therapeutics’s (IMUN) 50-day simple moving average is 0.18, creating a Sell signal.
Immune Therapeutics’s (IMUN) stock price is <$0.1 and Immune Therapeutics’s (IMUN) 100-day simple moving average is 0.35, creating a Sell signal.
Immune Therapeutics’s (IMUN) stock price is <$0.1 and Immune Therapeutics’s (IMUN) 200-day simple moving average is 0.48, creating a Sell signal.

Immune Therapeutics (IMUN) Technical Indicators

Apr 27, 2024, 10:49 PM
Name
Value
Implied Action
RSI (14)
25.09
Buy
STOCH (9,6)
53.97
Neutral
STOCHRSI (14)
53.97
Neutral
MACD (12,26)
-0.03
Sell
ADX (14)
67.85
Sell
Williams %R
-66.67
Buy
CCI (14)
-158.38
Buy
ATR (14)
0.02
-
Ultimate Oscillator
63.37
Neutral
ROC
-20.00
Sell
Immune Therapeutics’s (IMUN) Relative Strength Index (RSI) is 25.09, creating a Buy signal.
Immune Therapeutics’s (IMUN) Trend Strength Indicator (ADX) is 67.85, creating a Sell signal.
Immune Therapeutics’s (IMUN) Commodity Channel Index (CCI) is -158.38, creating a Buy signal.
Immune Therapeutics’s (IMUN) Price Rate of Change (ROC) is -20.00, creating a Sell signal.

FAQ

Is IMUN a Buy, Hold, or Sell?
Based on IMUN’s technical indicators, IMUN is a Strong Sell.
    What is IMUN’s RSI (14)?
    IMUN’s RSI (14) is 25.09, which suggests IMUN is a Buy.
      What is IMUN’s MACD?
      IMUN’s MACD is -0.03, which suggests IMUN is a Sell.
        What is IMUN’s 5-day moving average?
        IMUN’s 5-day moving average is 0.09, which suggests IMUN is a Sell.
          What is IMUN’s 20-day moving average?
          IMUN 20-day moving average is 0.10, which suggests IMUN is a Sell.
            What is IMUN’s 50-day moving average?
            IMUN’s 50-day moving average is 0.18, which suggests IMUN is a Sell.
              What is IMUN’s 200-day moving average?
              IMUN’s 200-day moving average is 0.48, which suggests IMUN is a Sell.
                What is IMUN’s Williams % R (14)?
                IMUN’s Williams % R (14) is -66.67, which suggests IMUN is a Buy.
                  What is IMUN’s CCI (14)?
                  IMUN’s CCI (14) is -158.38, which suggests IMUN is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis